Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort-Reference-Cited by-同舟云学术

Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort

Published:2022-10 Issue:1 Volume:167 Page:11-21
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Thomas Quentin Dominique,Boussere Amal,Classe Jean-Marc,Pomel Christophe,Costaz Hélène,Rodrigues Manuel,Ray-Coquard Isabelle,Gladieff Laurence,Rouzier Roman,Rouge Thibault De La Motte,Gouy Sébastien,Barranger Emmanuel,Sabatier Renaud,Floquet Anne,Marchal Frédéric,Guillemet Cécile,Polivka Valentine,Martin Anne-Laure,Colombo Pierre-Emmanuel,Fiteni Frédéric

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference38 articles.

1. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†;Colombo;Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.,2019

2. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N. Engl. J. Med.,2010

3. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial;Kehoe;Lancet,2015

4. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

5. Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan clinical oncology group study JCOG0602;Onda;Jpn. J. Clin. Oncol.,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial;Nature Communications;2024-07-16

2. Comparison of recurrence and survival between patients with pathological stage I epithelial ovarian cancer after laparoscopic or laparotomic surgery: retrospective analysis of a propensity-matched cohort;Journal of Minimally Invasive Gynecology;2024-07

3. Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial;Trials;2024-05-04

4. Utility of CA-125 in interval surgery;Obstetrics & Gynecology International Journal;2024-04-01

5. Radical Oophorectomy for Advanced Ovarian Cancer: A Feasibility Study from Tertiary Care Cancer Centre in Eastern India;The Journal of Obstetrics and Gynecology of India;2024-03-19